Inspire Medical Systems Posts $1.65 EPS and $269.1M Q4 Revenue
Inspire Medical Systems delivered Q4 adjusted EPS of $1.65 versus estimates of $0.69, a 137.7% surprise, and reported 12.3% revenue growth to $269.1 million. Shares have declined 26.1% year-to-date despite four consecutive quarters of upside surprises, while next-quarter consensus forecasts EPS of $0.01 on $212.6 million in sales.
1. Q4 Financial Results
Inspire Medical Systems delivered adjusted Q4 EPS of $1.65, beating consensus by 137.7% and rising from $1.15 a year earlier. Revenue grew 12.3% year-over-year to $269.1 million, marginally exceeding the $269.0 million estimate.
2. Consecutive Beat Streak
The report marked the fourth straight quarter of both EPS and revenue outperformance, following previous surprises including a 353.3% EPS upside in Q3. The company has now topped consensus forecasts in each of the past four periods.
3. Share Price Performance
Despite robust earnings and sales beats, shares have fallen 26.1% since the start of the year while the broader market gained 1.4%, highlighting investor caution in the medical device space. Underperformance reflects concerns over near-term growth sustainability.
4. Forward Estimates and Industry Standing
Analysts forecast next-quarter EPS of $0.01 on $212.6 million in revenue and full-year EPS of $1.72 with $1.0 billion in sales. The medical info systems industry ranks in the bottom 34%, underscoring sector challenges and competitive pressures.